Published in Blood on August 01, 1973
Long-range chromosomal interactions regulate the timing of the transition between poised and active gene expression. EMBO J (2007) 2.99
Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2. EMBO J (2004) 2.62
Analysis of hundreds of cis-regulatory landscapes at high resolution in a single, high-throughput experiment. Nat Genet (2014) 2.42
Coregulated human globin genes are frequently in spatial proximity when active. J Cell Biol (2006) 2.12
Chromatin signatures at transcriptional start sites separate two equally populated yet distinct classes of intergenic long noncoding RNAs. Genome Biol (2013) 1.41
Methyl binding domain protein 2 mediates gamma-globin gene silencing in adult human betaYAC transgenic mice. Proc Natl Acad Sci U S A (2006) 1.28
Analysis of the human alpha globin upstream regulatory element (HS-40) in transgenic mice. EMBO J (1992) 1.09
Causes and consequences of chromatin variation between inbred mice. PLoS Genet (2013) 0.89
Established epigenetic modifications determine the expression of developmentally regulated globin genes in somatic cell hybrids. Mol Cell Biol (1995) 0.89
Defining the cause of skewed X-chromosome inactivation in X-linked mental retardation by use of a mouse model. Am J Hum Genet (2007) 0.86
GFI1B controls its own expression binding to multiple sites. Haematologica (2009) 0.86
Unequal accumulation of alpha- and beta-globin mRNA in erythropoietic mouse spleen. Proc Natl Acad Sci U S A (1976) 0.86
Sequential activation of splenic nuclear RNA polymerases by erythropoietin. J Clin Invest (1976) 0.80
Tissue-specific CTCF-cohesin-mediated chromatin architecture delimits enhancer interactions and function in vivo. Nat Cell Biol (2017) 0.79
Regulated production of a pleiotropic cytokine-platelet-derived growth factor--by differentiating erythroid cells in vitro and in vivo. Proc Natl Acad Sci U S A (1995) 0.76
Pathways of retinoid synthesis in mouse macrophages and bone marrow cells. J Leukoc Biol (2016) 0.75
Cytokine dysregulation associated with malarial anemia in Plasmodium yoelii infected mice. Am J Transl Res (2013) 0.75
Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med (1998) 2.29
Hematologic abnormalities in the acquired immune deficiency syndrome. Am J Med (1984) 1.85
Polo-like kinase is a cell cycle-regulated kinase activated during mitosis. J Biol Chem (1995) 1.80
Methionyl soluble ribonucleic acid transformylase. I. Purification and partial characterization. J Biol Chem (1967) 1.74
Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med (1990) 1.72
Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors. JAMA (1988) 1.51
Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Ann Intern Med (1998) 1.51
Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine (Baltimore) (1988) 1.41
Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation. J Biol Chem (1991) 1.30
2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17 beta-estradiol metabolism in MCF-7 breast tumor cells. Proc Natl Acad Sci U S A (1990) 1.21
Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia. Arthritis Rheum (1988) 1.19
Pellagra: an analysis of 18 patients and a review of the literature. Johns Hopkins Med J (1977) 1.11
Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera. Blood (1999) 1.05
Suppression of hematopoietic-progenitor-cell proliferation by ethanol and acetaldehyde. N Engl J Med (1982) 1.04
The mechanism of action of erythropoietin. Int J Cell Cloning (1986) 1.02
Selective killing of leukemic cells by merocyanine 540-mediated photosensitization. Proc Natl Acad Sci U S A (1984) 1.01
Erythropoiesis in vitro. Role of calcium. J Clin Invest (1979) 0.99
Delineation of sites mediating estrogen regulation of the rat creatine kinase B gene. Mol Endocrinol (1992) 0.96
Felty's syndrome: an analytical review. Johns Hopkins Med J (1977) 0.96
Assessing the need for transfusion of premature infants and role of hematocrit, clinical signs, and erythropoietin level. Pediatrics (1989) 0.95
Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 breast cancer cells. J Cell Biochem (1991) 0.94
A mail survey of United States hematologists and oncologists: a comparison of business reply versus stamped return envelopes. J Clin Epidemiol (2001) 0.94
Recombinant human erythropoietin and the anemia of cancer. Blood (1994) 0.94
Chromate transport in human leukocytes. J Clin Invest (1970) 0.94
The quantitative JAK2 V617F neutrophil allele burden does not correlate with thrombotic risk in essential thrombocytosis. Leukemia (2007) 0.94
Estradiol preferentially enhances extracellular tissue plasminogen activators of MCF-7 breast cancer cells. J Biol Chem (1984) 0.93
Effect of reversible androgen deprivation on hemoglobin and serum immunoreactive erythropoietin in men. Am J Hematol (1991) 0.92
Suppression of estrogen-regulated extracellular tissue plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res (1987) 0.92
Erythropoietin: isolation by affinity chromatography with lectin-agarose derivatives. Proc Natl Acad Sci U S A (1977) 0.90
Richter's syndrome with two different B-cell clones. Cancer (1986) 0.90
Enhancement of 2- and 16 alpha-estradiol hydroxylation in MCF-7 human breast cancer cells by 2,3,7,8-tetrachlorodibenzo-P-dioxin. Biochem Biophys Res Commun (1988) 0.90
Systemic lupus erythematosus and myelofibrosis. Am J Med (1986) 0.90
Susceptibility to merocyanine 540-mediated photosensitization: a differentiation marker on murine hematopoietic progenitor cells. J Cell Physiol (1983) 0.89
Effect of Cibacron blue F3GA on oligonucleotide binding site of estradiol--receptor complexes of mouse uterine cytosol. Proc Natl Acad Sci U S A (1979) 0.89
Association between mediastinal germ cell tumors and hematologic malignancies. Report of two cases and review of the literature. Am J Surg Pathol (1985) 0.89
Tumor-promoting phorbol esters stimulate myelopoiesis and suppress erythropoiesis in cultures of mouse bone marrow cells. Proc Natl Acad Sci U S A (1981) 0.89
The erythropoietic mouse spleen-a model system of development. Arch Biochem Biophys (1976) 0.89
Magnitude of calcium influx required to induce dehydration of normal human red cells. Biochim Biophys Acta (1988) 0.88
Effect of ethanol on thrombopoiesis. Br J Haematol (1986) 0.87
Acquired immune deficiency syndrome and pancytopenia. JAMA (1983) 0.87
Estrogen regulation of creatine kinase-B in the rat uterus. Mol Endocrinol (1990) 0.87
Relationships between thrombopoiesis and erythropoiesis: with studies of the effects of preparations of thrombopoietin and erythropoietin. Blood (1976) 0.86
Interleukin 3 promotes the in vitro proliferation of murine pluripotent hematopoietic stem cells. J Clin Invest (1985) 0.86
Intracellular growth factors in polycythemia vera and other myeloproliferative disorders. Proc Natl Acad Sci U S A (1987) 0.86
Phagocytic tumour cells. Scand J Haematol (1973) 0.86
Anemia of cancer. Hematol Oncol Clin North Am (1996) 0.85
Regulation of hematopoiesis: helper and suppressor influences of the thymus. Blood (1980) 0.85
Separation of erythroid progenitor cells in mouse bone marrow by isokinetic-gradient sedimentation. Blood (1979) 0.85
Stimulation of erythroid colony formation in vitro by erythropoietin immobilized on agarose-bound lectins. J Lab Clin Med (1981) 0.85
Studies on splenic erythropoiesis in the mouse. I. Ribosomal ribonucleic acid metabolism. J Lab Clin Med (1972) 0.84
Erythropoietin response to anemia as a function of age. J Am Geriatr Soc (1991) 0.84
Hemochromatosis. Med Clin North Am (1989) 0.83
Stimulation of oligonucleotide binding of estradiol receptor complexes by accessory proteins. Nucleic Acids Res (1979) 0.83
Selective binding of mouse estradiol.receptor complexes to oligo(dT)-cellulose. J Biol Chem (1978) 0.83
Isolation of a distinct pool of polyribosomes from nuclei of adenovirus-infected Hela cells. Arch Biochem Biophys (1977) 0.82
Hepatitis-related hepatic erythropoietin production. Am J Med (1990) 0.82
Formymethionyl transfer ribonucleic acid transformylase: the specific interaction of the enzyme with its transfer ribonucleic acid substrate. J Mol Biol (1971) 0.81
Unusual case of acute leukemia. Coexisting acute leukemia and pernicious anemia. Am J Med (1984) 0.81
Defibrinogenation after intra-amniotic injection of hypertonic saline. N Engl J Med (1972) 0.81
Recombinant human erythropoietin therapy in end stage renal failure. J Clin Pharmacol (1988) 0.80
Dissimilar RNA and protein characteristics of polyribosomes of nuclear and cytoplasmic origin in adenovirus-infected cells. J Biol Chem (1979) 0.80
Sequential activation of splenic nuclear RNA polymerases by erythropoietin. J Clin Invest (1976) 0.80
A novel thrombopoietin signaling defect in polycythemia vera platelets. Stem Cells (1998) 0.80
Effect of chaotropic anions on the rate of dissociation of estradiol-receptor protein complexes of mouse uterine cytosol. Biochem Biophys Res Commun (1978) 0.80
The role of folate coenzymes in the initiation of protein synthesis. Ann N Y Acad Sci (1971) 0.79
Marrow cell necrosis in anorexia nervosa and involuntary starvation. Br J Haematol (1985) 0.79
Impaired erythropoietin response to anemia after bone marrow transplantation. Blood (1992) 0.79
Preparation of azoDNA and its use in affinity chromatography. Arch Biochem Biophys (1978) 0.79
Masked megaloblastic anemia. Arch Intern Med (1982) 0.79
Physiologic basis for the pharmacologic use of recombinant human erythropoietin in surgery and cancer treatment. Surgery (1994) 0.78
Hexamethylene bisacetamide in myelodysplastic syndrome: effect of five-day exposure to maximal therapeutic concentrations. Leukemia (1992) 0.78
Studies on methyl-deficient methionine transfer ribonucleic acid from Escherichia coli. J Biol Chem (1971) 0.78
Differential sensitivity of mouse hematopoietic stem cells to merocyanine 540. Differentiation (1981) 0.78
Effects of the differentiating agent hexamethylene bisacetamide on normal and myelodysplastic hematopoietic progenitors. J Natl Cancer Inst (1990) 0.78
Prothrombin levels are increased in the estrogen-treated immature rat uterus. Endocrinology (1990) 0.77
Use of immobilized lectins and other ligands for the partial purification of erythropoietin. Blood (1978) 0.77
Two types of plasminogen activators secreted by MCP-7 cells. Biochem Biophys Res Commun (1982) 0.77
An estrogen-stimulated, calcium-dependent tosylarginine methyl ester (TAME) hydrolase in immature rat uterus. Mol Cell Endocrinol (1983) 0.77
Homosexual men with thrombocytopenia have impaired reticuloendothelial system Fc receptor-specific clearance. Blood (1987) 0.76
Esterase A is a proteinase from rat urine that can activate plasminogen. Biochim Biophys Acta (1984) 0.76
Serum immunoreactive erythropoietin during the perioperative period. Surgery (1994) 0.76
Aminoacyl formylmethionyl transfer ribonucleic acid transformylase. Inhibitor studies and the reversal of the reaction. Biochemistry (1970) 0.76
Suppression and potentiation of mouse hematopoietic progenitor cell proliferation by ouabain. Blood (1980) 0.76
Erythropoietin and the regulation of erythropoiesis. Johns Hopkins Med J (1980) 0.76
In situ hybridization for creatine kinase-B messenger RNA in rat uterus and brain. Mol Cell Endocrinol (1993) 0.76
Post-seizure myoglobinuria. Johns Hopkins Med J (1969) 0.75
The expression and role of human erythropoietin receptor in erythroid and nonerythroid cells. Ann N Y Acad Sci (1994) 0.75
Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin. Am J Med (1990) 0.75
Calcium and the erythroblast. Exp Hematol (1992) 0.75
Estrogen control of uterine tissue factor messenger ribonucleic acid levels. Endocrinology (1992) 0.75
Specificity of oligodeoxynucleotide binding of mouse uterine cytosol estradiol receptors. Proc Natl Acad Sci U S A (1980) 0.75
The second international congress on myeloproliferative and myelodysplastic syndromes. Leuk Res (2004) 0.75
Clinical use of erythropoietin. Curr Opin Hematol (1995) 0.75
Effect of erythropoietin on chromosomal protein synthesis. Blood (1976) 0.75
Sterospecific tissue uptake and nuclear accumulation of testosterone in the development of the mouse erythropoietic spleen. Blood (1976) 0.75
Ligand binding kinetics of a soluble full-length murine erythropoietin receptor. Biochem Biophys Res Commun (1995) 0.75
The third International Congress on Myeloproliferative and Myelodysplastic Syndromes. Leuk Res (2006) 0.75